BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Emerging Biotech

TiumBio and Hansoh Pharma Secure NMPA Approval for 'HS-10518/TU2670' Clinical Trial in China

TiumBio will complete the last patient dosing in a Phase 2a clinical trial of TU2670 in endometriosis in Europe by the end of the year TiumBio C...

July 06, 2023 | News

Innovent and IASO Bio Receive NMPA Approval for FUCASO®, a Fully-human BCMA CAR-T Therapy for Multiple Myeloma

Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality me...

July 03, 2023 | News

Lifera and CENTOGENE Form Strategic Saudi Joint Venture for Enhanced Multiomic Testing Access

Joint Venture (JV) combines CENTOGENE's global leadership in multiomics with local insight of Lifera, a biopharmaceutical company wholly own...

July 03, 2023 | News

Lion TCR Raises $40M in Series B2 Funding, Revolutionizing Solid Tumor Treatment with mRNA-Encoding TCR-T Cell Therapy

The funds raised will be used primarily to support Lion TCR's clinical trials on hepatitis B virus (HBV)-specific TCR T cell therapy, while also facilitati...

June 28, 2023 | News

Psylo Partners with Daiichi Sankyo for Non-Hallucinogenic Psychiatric Therapies

Biotech start-up, Psylo, announced that it has entered into a Sponsored Research Agreement with global Japanese pharmaceutical company, Daiichi ...

June 23, 2023 | News

"Jumar Bioincubator" calls for next-gen biotechs, appoints new GM

The "Jumar Bioincubator" will be supported by cash and in-kind contributions of approximately $45 million over ten years from its founding partne...

June 22, 2023 | News

AstraZeneca Collaborates with Cholesgen for Hypercholesterolemia Drug Discovery and Licensing Agreement

This three-year collaboration aims to validate genetic drug targets and progress therapeutic molecules into clinical development. The joint resea...

June 19, 2023 | News

Viva Biotech Announced Strategic Investors with an Investment of Approximately US$ 210 Million

Based on its SBDD strategy, Viva Biotech has achieved remarkable growth in its CRO drug discovery and development business through its continuous effort th...

June 16, 2023 | News

Cytiva's BioChallenge Empowers Southeast Asian Biotech Startups to Advance Therapeutic Innovations

In an exclusive interview, Prem Mandalapu, General Manager, Commercial, ASEAN at Cytiva, sheds light on Cytiva's BioChallenge and its objective of supporti...

June 15, 2023 | Influencers

Beaconcure Raises $14 Million Series B to Expand AI-powered Clinical Technology Platform

NewVale Capital leads $14 Million Series B growth round Industry leading executive, Rick Riegel, joins as Chairman of the Board Newly formed Strategic ...

June 14, 2023 | News

Sirnaomics to Unveil GalAhead™ Therapeutic Platform Updates at Industry Conferences

The Company's first GalAhead™-based RNAi drug candidate, STP122G, has started a Phase I clinical trial in May 2023. The start of the trial indic...

June 14, 2023 | News

Eccogene Raises CNY 180M in Series B Financing for Metabolic Disease Treatments

Eccogene Inc., a clinical-stage biotechnology company developing innovative therapeutic solutions for metabolic diseases, announced a CNY 1...

June 12, 2023 | News

DxVx Wins Government Project for Adult Disease Diagnostic Sensor Kit

DxVx announced that it won the national project, 'Korea-led K-Sensor Technology Development for Market Leadership' supported by the Ministry of Trade, Indu...

June 12, 2023 | News

BetaLife wins Cytiva’s first BioChallenge Competition in Southeast Asia

Cytiva’s BioChallenge aims to support the innovation of biotech startups. Cytiva recognizes the talent, resource and scalability constraints faced b...

June 07, 2023 | News

Stay Connected